Rituximab May Ease Idiopathic Membranous Nephropathy

Share this content:

Patients with idiopathic membranous nephropathy (IMN) may benefit from treatment with rituximab. John Schieszer reports in today's Medical Minute that this agent may be effective in IMN patients even when previous treatments with steroids and other immunosuppressive agents have failed.
You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters